Skip to content

Clinical study on the treatment of mild and moderate cervical radiculopathy by Supine Pulling Manipulation

Clinical study on the treatment of mild and moderate cervical radiculopathy by Supine Pulling Manipulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065140
Enrollment
Unknown
Registered
2022-10-29
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical radiculopathy

Interventions

treatment group:Supine Pulling Manipulation
control group:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of cervical radiculopathy. (2) The age ranges from 25 to 65. (3) The course of the disease is less than (or equal to) 5 years. (4) 2=VAS score =5. (5) Volunteer to participate in the trial study and sign the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: (1) No be involved in other clinical trials to treat cervical radiculopathy. (2) Progressive atrophy of the muscles innervated by cervical radiculopathy. (3) Patients with cervical spondylotic myelopathy or more severe cervical spondylotic vertebral artery disease. (4) There is severe wound or skin disease at the treatment location. (5) Pregnancy or lactation. (6) Be suspected of upper central nervous diseases such as stroke and Parkinson's disease. (7) Be suspected of cardiac diseases such as arrhythmia, coronary heart disease, and myocardial infarction. (8) Patients with active gastrointestinal ulcers/bleeding or previous recurrent ulcers/bleeding. (9) Allergic to etoricoxib or other NSAIDs. (10) Patients who have asthma, hives, or allergic reactions after taking aspirin. (11) Patients with Congestive heart failure (New York Cardiology Society [NYHA] Cardiac Function Class II-IV). (12) Patients with ischemic heart disease, peripheral artery disease, or cerebrovascular disease (including patients who have recently undergone coronary artery bypass grafting or angioplasty)

Design outcomes

Primary

MeasureTime frame
visual analogue scale (VAS);Neck Disability Index;Patient Specific Functional Scale;

Countries

China

Contacts

Public ContactDingkun Lin

Guangdong Provincial Hospital of Chinese Medicine

lindingkun@126.com13602852486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026